Clinical Trials Browser

Prostatic Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Lung Neoplasms, Small Cell Lung Carcinoma

Squamous Cell Carcinoma of Head and Neck

Non Small Cell Lung Cancer Metastatic

Brain Neoplasms, Lung Neoplasms, Small Cell Lung Carcinoma

Brain Neoplasms, Melanoma

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Brain Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

Unresectable Locally Recurrent Rectal Cancer

Lung Squamous Cell Carcinoma

Breast Neoplasms

Carcinoma, Renal Cell, Disease Progression

Prostatic Neoplasms

Neoplasm Metastasis, Hematologic Neoplasms

Brain Neoplasms

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Neoplasm Metastasis

Breast Neoplasms

Breast Neoplasms

Castrate Resistance Prostate Cancer

Carcinoma, Renal Cell

Pancreatic Neoplasms

Colorectal Neoplasms

Prostatic Neoplasms

Oligometastatic Prostate Cancer

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Neoplasm Metastasis

Ovarian Neoplasms

Local Recurrence of Malignant Tumor of Prostate

Neoplasm Metastasis

Unresectable Locally Recurrent Rectal Cancer

Carcinoma, Hepatocellular

Anal Canal Carcinoma, Neoplasm Metastasis, Colorectal Neoplasms, Neuroendocrine Tumors

HR-positive,HER2-negative Breast Cancer

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Brain Neoplasms, Breast Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

Clinical Trials

Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor

T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy

SBRT Lung

SHARP

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis

3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial

A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer

ABC-X

ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer

Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer

Frameless Stereotactic Radiosurgery for Intact Brain Metastases

DIVINE

Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases

Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer

Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer

Combined Immunotherapies in Metastatic ER+ Breast Cancer

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

LUST

Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

SPORTSMEN

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

SECURE

A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy

EMPIRE

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

EXCALIBUR

SBRT-AMICO

A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer

Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma

Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer

SOPRANO

Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma

PROSTARE

OLIGO-10

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）

Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.

HSBRT2402

Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases